相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Understanding Structure-Function Relationships of Nanoadjuvants for Enhanced Cancer Vaccine Efficacy
Jia Tan et al.
ADVANCED FUNCTIONAL MATERIALS (2022)
Mechanisms of nanoparticle radiosensitization
Ivan Kempson
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2021)
Aluminium adjuvants in vaccines-A way to modulate the immune response
Ravi Danielsson et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2021)
Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
Stefania Cuzzubbo et al.
FRONTIERS IN IMMUNOLOGY (2021)
Engineering aluminum hydroxyphosphate nanoparticles with well-controlled surface property to enhance humoral immune responses as vaccine adjuvants
Zhihui Liang et al.
BIOMATERIALS (2021)
Crystalline and Amorphous Preparation of Aluminum Hydroxide Nanoparticles Enhances Protective Antigen Domain 4 Specific Immunogenicity and Provides Protection Against Anthrax
Himanshu Gogoi et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Aluminum Nanoparticles Acting as a Pulmonary Vaccine Adjuvant-Delivery System (VADS) Able to Safely Elicit Robust Systemic and Mucosal Immunity
Ning Wang et al.
JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS (2020)
Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant-Antigen Codelivery
Zhi-Biao Wang et al.
VACCINES (2020)
NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
Shaima'a Hamarsheh et al.
FRONTIERS IN IMMUNOLOGY (2020)
Albumin-biomineralized nanoparticles to synergize phototherapy and immunotherapy against melanoma
Yining Zhu et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Co-delivery of antigen and dual adjuvants by aluminum hydroxide nanoparticles for enhanced immune responses
Yingying Hou et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Tumor cell membrane enveloped aluminum phosphate nanoparticles for enhanced cancer vaccination
Jingyao Gan et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Co-Administration of Aluminium Hydroxide Nanoparticles and Protective Antigen Domain 4 Encapsulated Non-Ionic Surfactant Vesicles Show Enhanced Immune Response and Superior Protection against Anthrax
Himanshu Gogoi et al.
VACCINES (2020)
Nanoparticles as Adjuvants in Vaccine Delivery
Anuj Garg et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2020)
Physicochemical structure of a polyacrylic acid stabilized nanoparticle alum (nanoalum) adjuvant governs TH1 differentiation of CD4+T cells
Amit P. Khandhar et al.
NANOSCALE (2020)
A comparison between adjuvant and delivering functions of calcium phosphate, aluminum hydroxide and chitosan nanoparticles, using a model protein of Brucella melitensis Omp31
M. Abkar et al.
IMMUNOLOGY LETTERS (2019)
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang Yang et al.
CELL DEATH & DISEASE (2019)
Covering Aluminum Oxide Nanoparticles with Biocompatible Materials to Efficiently Deliver Subunit Vaccines
Ning Wang et al.
VACCINES (2019)
Stabilised aluminium phosphate nanoparticles used as vaccine adjuvant
Hilde Vrieling et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
Aluminum oxide nanowires as safe and effective adjuvants for next-generation vaccines
Rostyslav Bilyy et al.
MATERIALS TODAY (2019)
Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology
Mark T. Orr et al.
NPJ VACCINES (2019)
Turning the Old Adjuvant from Gel to Nanoparticles to Amplify CD8(+) T Cell Responses
Hao Jiang et al.
ADVANCED SCIENCE (2018)
Current challenges for cancer vaccine adjuvant development
William S. Bowen et al.
EXPERT REVIEW OF VACCINES (2018)
Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells
Heng Dong et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Uric acid and the vaccine adjuvant activity of aluminium (oxy)hydroxide nanoparticles
Sachin G. Thakkar et al.
JOURNAL OF DRUG TARGETING (2018)
Manipulating extracellular tumour pH: an effective target for cancer therapy
Guanyu Hao et al.
RSC ADVANCES (2018)
Mechanistic study of the adjuvant effect of chitosan-aluminum nanoparticles
F. Lebre et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Crumpled Aluminum Hydroxide Nanostructures as a Microenvironment Dysregulation Agent for Cancer Treatment
Marat I. Lerner et al.
NANO LETTERS (2018)
Inhibiting the CD8+ T cell infiltration in the tumor microenvironment after radiotherapy is an important mechanism of radioresistance
Hai-yan Chen et al.
SCIENTIFIC REPORTS (2018)
Aluminum hydroxide nanoparticles show strong activity to stimulate Th-1 immune response against tuberculosis
Yousef Amini et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2017)
Mechanisms governing inflammasome activation, assembly and pyroptosis induction
Sannula Kesavardhana et al.
INTERNATIONAL IMMUNOLOGY (2017)
Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles
Haiyue Xu et al.
VACCINE (2017)
Alkalization of Tumor Microenvironment for Cancer Treatment
A. S. Lozhkomoev
PHYSICS OF CANCER: INTERDISCIPLINARY PROBLEMS AND CLINICAL APPLICATIONS (PC IPCA) (2017)
Enhanced Immune Adjuvant Activity of Aluminum Oxyhydroxide Nanorods through Cationic Surface Functionalization
Bingbing Sun et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Aluminum (Oxy)Hydroxide Nanosticks Synthesized in Bicontinuous Reverse Microemulsion Have Potent Vaccine Adjuvant Activity
Xu Li et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Adjuvants in micro- to nanoscale: current state and future direction
Ankur Gupta et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2016)
Metal oxide nanoparticles interact with immune cells and activate different cellular responses
Rosana Simon-Vazquez et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles
Tinashe B. Ruwona et al.
VACCINE (2016)
Adjuvants: Classification, Modus Operandi, and Licensing
Juliana de Souza Apostolico et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations
Matthew Mold et al.
SCIENTIFIC REPORTS (2016)
Phospholipid Bilayer-Coated Aluminum Nanoparticles as an Effective Vaccine Adjuvant-Delivery System
Ting Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
Nikolai Petrovsky
DRUG SAFETY (2015)
Suppression of established hepatocarcinoma in adjuvant only immunotherapy: alum triggers anti-tumor CD8+ T cell response
Bo Wang et al.
SCIENTIFIC REPORTS (2015)
Polarized immune responses modulated by layered double hydroxides nanoparticle conjugated with CpG
Shiyu Yan et al.
BIOMATERIALS (2014)
Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles
Xinran Li et al.
JOURNAL OF CONTROLLED RELEASE (2014)
The impact of size on particulate vaccine adjuvants
Ruchi R. Shah et al.
NANOMEDICINE (2014)
Unequivocal identification of intracellular aluminium adjuvant in a monocytic THP-1 cell line
Matthew Mold et al.
SCIENTIFIC REPORTS (2014)
Engineering an Effective Immune Adjuvant by Designed Control of Shape and Crystallinity of Aluminum Oxyhydroxide Nanoparticles
Bingbing Sun et al.
ACS NANO (2013)
Disparate adjuvant properties among three formulations of alum
Derek W. Cain et al.
VACCINE (2013)
Mechanism of immunopotentiation and safety of aluminum adjuvants
Harm HogenEsch
FRONTIERS IN IMMUNOLOGY (2013)
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2011)
Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response
Haiyan Li et al.
NATURE NANOTECHNOLOGY (2011)
GAD-alum treatment in patients with type 1 diabetes and the subsequent effect on GADA IgG subclass distribution, GAD65 enzyme activity and humoral response
Mikael Cheramy et al.
CLINICAL IMMUNOLOGY (2010)
Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection
Laura Bungener et al.
VACCINE (2008)
Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm
Tian Xia et al.
NANO LETTERS (2006)
Challenges facing adjuvants for cancer immunotherapy
C Mesa et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Alkyl-polyacrylate esters are strong mucosal adjuvants
LAT Hilgers et al.
VACCINE (2000)
分享论文
